Article Correctness Is Author's Responsibility: Positive PET Results and Hippocampal Volume Predict Progression From MCI to Dementia

The article below may contain offensive and/or incorrect content.

An international team of investigators assessed the ability of flutemetamol F 18-labeled PET and other biomarkers to predict risk of clinical progression from amnestic mild cognitive impairment to probable Alzheimer disease.